Angie Collier-Crespin

Learn More
To date, there have been few surveys of psychotropic and antiepileptic drug (AED) prevalence in individuals with autism-spectrum conditions. We surveyed 747 families in the Autism Society of Ohio regarding the use of psychotropic drugs, AEDs, and over-the-counter (OTC) preparations for autism. In all, 417 families (55.8%) replied. A total of 45.6% were(More)
Assessment of autistic disorder (autism) symptoms, primary and secondary, poses more challenging problems than ordinarily found in multisite randomized clinical trial (RCT) assessments. For example, subjects may be uncommunicative and extremely heterogeneous in problem presentation, and current pharmacological treatments are not likely to alter most core(More)
Objective: Twenty children with attention-deficit/hyperactivity disorder (ADHD) and low IQs, who participated in a drug study, were followed-up 4.5 years later, when their ages averaged 12.4 years (range: 8-20 years; SD=2.78). Method: Participants were assessed by their parents and teachers on the and on a structured interview. Results: A majority of(More)
This is a review of pharmacotherapy in children and adolescents with mental retardation from the perspective of DSM and ICD disorders. The existing research is reviewed in young people with mental retardation but, when data are lacking, we examined the literature from adults with mental retardation and from typically-developing children. The literature is(More)
  • D Annequin, Massiou, P Brna, J Dooley, K Gordon, Dewan +139 others
  • 2010
The prognosis of childhood headache: a 20-year follow-up. treatment of migraine in children. Part 2. A systematic review of pharmacological trials. Symptomatic treatment of migraine in children: a systematic review of medication trials. and prognosis of migraine and tension-type headache in children and adolescents: a long-term follow-up study. significant(More)
  • 1